Wharton Jöle-Mezenkimal Kök Hücreleri Kullanılarak COVİD-19 Hastalarının Tedavisi
Brief Summary:Bu çalışmanın amacı Wharton Jelly Mezenkimal kök hücrelerinin potansiyel kullanımını araştırmaktır. (WJ-MSC'ler) Corona Virüsü SARS-CoV-2 enfeksiyonu tanısı konulan hastanın tedavisi için, ve COVİD-19 belirtileri gösteriyor.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Use ofKök hücreler for COVID-19 Treatment | Biological: WJ-MSC'ler | Phase 1 |
Detaylı Açıklama:
COVID-19 is a condition caused by infection with Coronoa Virus (SARS-CoV-2). This virus has a high transmission rate and is spreading at very high rates. causing a worldwide pandemic. Patients diagnosed with COVID-19 and confirmed positive with the virus, will be given three IV doses of WJ-MSCs consisting of 1X10e6/kg. The three doses will be 3 days apart form each other.
Patients will be followed up for a period of three weeks to assess the severity of the condition and measure the viral titers.
